Related Experiment Video
Updated: Jun 28, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Serum micro-RNAs with mutation-targeted RNA modification: a potent cancer detection tool constructed using an
Wei Liao1, Yuyan Xu2, Mingxin Pan3
1Department of Hepatobiliary Surgery, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Abstract:
RNA modifications affect fundamental biological processes and diseases and are a research hotspot. Several micro-RNAs (miRNAs) exhibit genetic variant-targeted RNA modifications that can greatly alter their biofunctions and influence their effect on cancer. Therefore, the potential role of these miRNAs in cancer can be implicated in new prevention and treatment strategies. In this study, we determined whether RMvar-related miRNAs were closely associated with tumorigenesis and identified cancer-specific signatures based on these miRNAs with variants targeting RNA modifications using an optimized machine learning workflow. An effective machine learning workflow, combining least absolute shrinkage and selection operator analyses, recursive feature elimination, and nine types of machine learning algorithms, was used to screen candidate miRNAs from 504 serum RMvar-related miRNAs and construct a diagnostic signature for cancer detection based on 43,047 clinical samples (with an area under the curve value of 0.998, specificity of 93.1%, and sensitivity of 99.3% in the validation cohort). This signature demonstrated a satisfactory diagnostic performance for certain cancers and different conditions, including distinguishing early-stage tumors. Our study revealed the close relationship between RMvar-related miRNAs and tumors and proposed an effective cancer screening tool.
Insights
Researchers identified RNA modification-related microRNAs (miRNAs) linked to cancer. A machine learning model using these miRNAs achieved high accuracy in detecting various cancers, including early stages, offering a potential new screening tool.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- RNA modifications are crucial in biological processes and disease, with micro-RNAs (miRNAs) playing a key role.
- Genetic variants targeting RNA modifications in miRNAs can significantly alter their function and impact cancer development.
Purpose of the Study:
- To investigate the association between RNA modification-related miRNA variants (RMvar-related miRNAs) and tumorigenesis.
- To develop a cancer-specific diagnostic signature using RMvar-related miRNAs and machine learning.
Main Methods:
- Utilized an optimized machine learning workflow combining LASSO, RFE, and nine ML algorithms.
- Screened 504 serum RMvar-related miRNAs to identify candidate biomarkers.
- Constructed and validated a diagnostic signature using a large cohort of 43,047 clinical samples.
Main Results:
- The developed signature demonstrated exceptional diagnostic performance: AUC of 0.998, 93.1% specificity, and 99.3% sensitivity in the validation cohort.
- The signature showed satisfactory diagnostic capabilities across various cancers and conditions.
- Successfully distinguished early-stage tumors, highlighting its potential for early cancer detection.
Conclusions:
- RMvar-related miRNAs are closely associated with tumor development.
- The proposed miRNA-based signature serves as an effective tool for cancer screening and early detection.
More Related Videos
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs

